MAM
PFE icon

Mark Asset Management’s Pfizer PFE Stock Holding History

Mark Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-41,760
Closed -$2.47M – 56
2021
Q4 		$2.47M Buy
41,760
+19,735
+90% +$978K 0.28% 40
2021
Q3 		$947K Buy
22,025
+10,025
+84% +$444K 0.1% 49
2021
Q2 		$470K Buy
+12,000
New +$467K 0.06% 47

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Mark Asset Management's PFE Position: Q1 2022 in Review

Mark Asset Management sold out of Pfizer (PFE) in Q1 2022, closing a stake of 41,760 shares — an estimated $2.47M sold.

Mark Asset Management first reported a position in PFE in Q2 2021 and held it in 3 quarters. The position peaked at $2.47M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Mark Asset Management reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • Mark Asset Management sold 41,760 Pfizer shares in Q1 2022, an estimated $2.47M.
  • Mark Asset Management first reported a position in Pfizer in Q2 2021 and held it in 3 quarters.
  • Mark Asset Management's Pfizer position peaked at $2.47M in Q4 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Mark Asset Management's 13F filing for Q1 2022, filed 16 May 2022.